ELOXEloxx Pharmaceuticals, Inc.
20.98USD+15.53%Mkt Cap: 72.08M $P/E: 5.963d ago
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap72.08M $
Enterprise Value22.69M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-6.00M $
Revenue/Share—
Last Price20.98 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees10
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS29014R2022
Valuation
P/E (Trailing)5.96
P/E (Forward)-25.41
PEG1.85
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.57
EPS (TTM)3.44
EPS (Forward)-0.71
52W Range
0.000090% of range23.40
52W High23.40 USD
52W Low0.0000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE50.35%
ROA-113.76%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.33M $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-50.13M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.08
Current Ratio3.74
Quick Ratio3.65
Book Value/Sh11.50 USD
Cash/Share15.35 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 20, 2017
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)41.50 USD
Upside (mean)+97.9%
Target Range40.00 USD – 43.00 USD
$40.00+97.9% to mean$43.00
# Analysts2
Ownership
Shares Out.3.44M
Float931.13K
Insiders26.28%
Institutions81.02%
Short Interest
Short Ratio0.2d
Short % Float0.55%
Short % Out.0.48%
Shares Short16.59K
Short (prev mo.)7.75K
Technical
SMA 5014.12 (+48.6%)
SMA 20014.06 (+49.2%)
Beta-160692.25
S&P 52W Chg18.16%
Avg Vol (30d)61.25K
Avg Vol (10d)42.32K
Technical Indicators
RSI (14)71.7
MACD1.9708
MACD Signal1.8715
MACD Hist.+0.0992
BB Upper22.46 USD
BB Middle16.59 USD
BB Lower10.71 USD
BB Width70.84%
ATR (14)2.193 USD
Vol Ratio (20d)1.42x